Ms. Urling joined Noveome in 2019 with over 24 years of clinical research and global trial management experience with large pharmaceutical and biotech corporations.  She started her clinical research career at the University of Pittsburgh conducting trials in the Medical Intensive Care Unit which eventually led her to transition to a career within industry.  She comes to Noveome having held clinical site management and study project management roles at companies such as Merck, Amgen, Abbott/AbbVie and Pfizer.  Her expertise involves direct planning and successful execution of phase 1-4 clinical trials and will be driving the development of Noveome’s clinical pipeline.  Ms. Urling holds a bachelor’s degree from the University of Pittsburgh in Communication Science and Disorders in association with a strong scientific background.